Abstract
In the present study, four different types of fourth-generation pegylated citric acid based dendrimers namely PE/TMP-MC-PEG-CA-PEG and PE/TMP-MS-PEG-CA-PEG were synthesized. The dendrimers were further conjugated with cefotaxime (CFTX) sodium drug. The structures of these dendrimers and drug-dendrimer conjugates were confirmed by using 1H-NMR, 13C-NMR, and FTIR spectroscopy. The confirmation of particle size, surface topography and structure of drug-dendrimer conjugates was done using Zeta sizer, AFM, and HR-TEM techniques. Cytotoxicity investigation revealed that the CFTX-encapsulated dendrimers are safe against normal epithelial cells and showed 20–22% anticancer activity against A549 Lung carcinoma cells; besides that, the synthesized dendrimers and drug-dendrimer conjugates also showed 15–28% and 2–3% hemolytic toxicity, respectively, against red blood cells (RBC). The antibacterial activity of all synthesized third and fourth generation drug-dendrimer conjugates were investigated on Gram-positive and Gram-negative bacteria. The results show that drug conjugate with third generation dendrimers depicted a greater effective zone of inhibition (ZOI) as compared to fourth generation drug-dendrimer conjugates against these pathogenic bacteria.
Similar content being viewed by others
Data Availability
The data will be available from the authors on demand.
References
Tiwari K, Bhattacharya S (2022) The ascension of nanosponges as a drug delivery carrier: preparation, characterization, and applications. J Mater Sci Mater Med 33(3):28
Chang M, Zhang F, Wei T, Zuo T, Guan Y, Lin G, Shao W (2016) Smart linkers in polymer-drug conjugates for tumor-targeted delivery. J Drug Target 24(6):475–491
Dheer D, Arora D, Jaglan S, Rawal RK, Shankar R (2017) Polysaccharides based nanomaterials for targeted anti-cancer drug delivery. J Drug Target 25(1):1–16
Mekuria SL, Debele TA, Chou HY, Tsai HC (2016) IL-6 antibody and RGD peptide conjugated poly(amidoamine) dendrimer for targeted drug delivery of HeLa cells. J Phys Chem B 120(1):123–130
Edgar JYC, Wang H (2016) Introduction for design of nanoparticle based drug delivery systems. Curr Pharm Des 23(14):2108–2112
Kaur A, Jain K, Mehra NK, Jain NK (2017) Development and characterization of surface engineered PPI dendrimers for targeted drug delivery. Artif Cells Nanomed Biotechnol 45(3):414–425
Boas U, Söntjens SHM, Jensen KJ, Christensen JB, Meijer EW (2002) New dendrimer - Peptide host - Guest complexes: Towards dendrimers as peptide carriers. ChemBioChem 3(5):433–439
Sagir T, Huysal M, Senel M, Isık S, Burgucu N, Tabakoglu O, Zaim M (2022) Folic acid conjugated PAMAM-modified mesoporous silica-coated superparamagnetic iron oxide nanoparticles for potential cancer therapy. J Colloid Interface Sci 625:711–721
Xu KF, Jia HR, Zhu YX, Liu X, Gao G, Li YH, Wu FG (2019) Cholesterol-modified dendrimers for constructing a tumor microenvironment-responsive drug delivery system. ACS Biomater Sci Eng 5(11):6072–6081
Ban J, Li S, Zhan Q, Li X, Xing H, Chen N, Long L, Hou X, Zhao J, Yuan X (2021) PMPC modified PAMAM dendrimer enhances brain tumor-targeted drug delivery. Macromol Biosci 21(4):1–13
Najafi F, Ghasemian N, Safari M, Salami-Kalajahi M (2021) Poly(propylene imine) dendrimer as reducing agent for chloroauric acid to fabricate and stabilize gold nanoparticles. J Phys Chem Solids 148:109682
Alexandridis P (2011) Gold nanoparticle synthesis, morphology control, and stabilization facilitated by functional polymers. Chem Eng Technol 34(1):15–28
Gu Z, Wang M, Fang Q, Zheng H, Wu F, Lin D, Xu Y, Jin Y (2015) Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery. Drug Dev Ind Pharm 41(5):812–818
Kesharwani P, Jain K, Jain NK (2014) Dendrimer as nanocarrier for drug delivery. Prog Polym Sci 39(2):268–307
Madaan K, Kumar S, Poonia N, Lather V, Pandita D (2014) Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci 6(3):139–150
Kaur D, Jain K, Mehra NK, Kesharwani P, Jain NK (2016) A review on comparative study of PPI and PAMAM dendrimers. J Nanoparticle Res 18(6):1–14
Zhou LP, Li JW, Yu B, Zhang J, Hu H, Cong HL, Shen YQ (2023) The drug loading behavior of PAMAM dendrimer: Insights from experimental and simulation study. Sci China Technol Sci 66(4):1129–1140
Chandra S, Dietrich S, Lang H, Bahadur D (2011) Dendrimer-Doxorubicin conjugate for enhanced therapeutic effects for cancer. J Mater Chem 21(15):5729–5737
Alfei S, Castellaro S (2017) Synthesis and characterization of polyester-based dendrimers containing peripheral arginine or mixed amino acids as potential vectors for gene and drug delivery. Macromol Res 25(12):1172–1186
Namazi H, Adeli M (2005) Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents. Biomaterials 26(10):1175–1183
Namazi H, Hamrahloo YT (2011) Novel PH sensitive nanocarrier agents based on citric acid dendrimers containing conjugated β-cyclodextrins. Adv Pharm Bull 1(1):40–47
Qi R, Gao Y, Tang Y, He RR, Le LT, He Y, Sun S, Li BY, Li YB, Liu G (2009) PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression. AAPS J 11(3):395–405
Zakaria AS, Afifi SA, Elkhodairy KA (2016) Newly developed topical cefotaxime sodium hydrogels: antibacterial activity and in vivo evaluation. Biomed Res Int [Internet]. 2016 [cited 2024 Jan 30]
Valikala V, Santhakumar I, Kannappan S (2019) Synthesis and effect of pegylation on citric acid dendritic nano architectures anchored with cefotaxime sodium. J Photochem Photobiol B Biol [Internet] 201(November):111683
Bushra MU (2014) Development and validation of a simple UV spectrophotometric method for the determination of cefotaxime sodium in bulk and pharmaceutical formulation. IOSR J Pharm 04(01):74–77
Kumar S, Randhawa JK (2013) Preparation and characterization of Paliperidone loaded solid lipid nanoparticles. Colloids Surfaces B Biointerfaces 102:562–568
Peng Z, Li H, Ba X, Zhao J, Sun X, Li Y (2016) Synthesis of TiO2 nanoparticles in the PAMAM hydrogen network template. E-Polymers 16(3):177–180
Prieto MJ, Del Rio Zabala NE, Marotta CH, Gutierrez HC, Arevalo RA, Chiaramoni NS, Alonso SDV (2014) Optimization and in vivo toxicity evaluation of g4.5 pamam dendrimer-risperidone complexes. PLoS ONE 9(2):1–10
Pan G, Lemmouchi Y, Akala EO, Bakare O (2005) Studies on PEGylated and drug-loaded PAMAM dendrimers. J Bioact Compat Polym 20(1):113–128
Dash S, Murthy PN, Nath L, Chowdhury P (2010) Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm - Drug Res 67(3):217–223
Salome AC, Godswill CO, Ikechukwu IO (2013) Kinetics and mechanisms of drug release from swellable and non swellable matrices: A review. Res J Pharm Biol Chem Sci 4(2):97–103
Kaundal R, Kumar M, Kumar S, Singh D, Kumar D (2022) Polyphenolic profiling, antioxidant, and antimicrobial activities revealed the quality and adaptive behavior of viola species, a dietary spice in the himalayas. Molecules 27(12):3867
Kapoor S, Padwad YS (2023) Phloretin induces G2/M arrest and apoptosis by suppressing the β-catenin signaling pathway in colorectal carcinoma cells. Apoptosis 28(5–6):810–829
Patel PM, Patel R, Wadia D, Patel RM (2015) Dendritic macromolecules as nano-scale drug carriers: Phase solubility, in vitro drug release, hemolysis and cytotoxicity study. Asian J Pharm Sci 10(4):306–313
Wang W, Xiong W, Zhu Y, Xu H, Yang X (2010) Protective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells. J Biomed Mater Res - Part B Appl Biomater 93(1):59–64
Acknowledgements
The authors are grateful to Ministry of Human Resource Development (MHRD), India, National Institute of Technology Hamirpur, Himachal Pradesh, India, for funding the research and RK Government Medical College Hamirpur for providing fresh human blood to perform the hemolytic toxicity of drug-dendrimer conjugates.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author assures that they have no financial or personal relationships that would have appeared to conflict with or appear to have an impact on their work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chand, A., Gaur, B. & Kapoor, S. Synthesis, characterization and evaluation of pegylated-citric acid based dendrimers as drug delivery agents. J Polym Res 31, 61 (2024). https://doi.org/10.1007/s10965-024-03908-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10965-024-03908-6